(Mary Ann Liebert, Inc./Genetic Engineering News) A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2y4F1FC
No comments:
Post a Comment